跳至主要内容
临床试验/NCT07046702
NCT07046702招募中不适用

68Ga-MY6349 PET/CT in Solid Tumors and Compared With 18F-FDG PET/CT

The First Affiliated Hospital of Xiamen University1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2024年12月10日最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
300
试验地点
1
主要终点
Evaluate the feasibility of PET/CT imaging with 68Ga-MY6349 for the non-invasive assessment of Trop2 expression in various cancer types.

研究概览

简要总结

The objective of the study is to construct a noninvasive approach 68Ga-MY6349 PET/CT to detect the Trop-2 expression of tumor lesions in patients with solid tumors and to identify patients benefiting from Trop-2 PET/CT.

详细描述

As a new trophoblast cell-surface antigen 2 (Trop-2) targeting PET radiotracer, 68Ga-MY6349 is promising as an excellent imaging agent applicable to various cancers. In this research, subjects with various types of tumors underwent contemporaneous 68Ga-MY6349 and standard-of-care imaging (18F-FDG) either for an initial assessment or for recurrence detection. Tumor uptake was quantified by the maximum standard uptake value (SUVmax). The numbers of positive tumor lesions of standard-of-care imaging and 68Ga-MY6349 PET/CT were recorded by visual interpretation. The diagnostic accuracy of 68Ga-MY6349 was calculated and compared to standard-of-care imaging.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • adult patients (aged 18 years or older)
  • patients with suspected or newly diagnosed or previously treated malignant tumors (supporting evidence may include MRI, CT, tumor markers and pathology report)
  • patients who had scheduled both standard-of-care imaging and 68Ga-MY6349 PET/CT scans
  • patients who were able to provide informed consent (signed by participant, parent or legal representative) and assent according to the guidelines of the Clinical Research Ethics Committee

排除标准

  • patients with pregnancy
  • the inability or unwillingness of the research participant, parent or legal representative to provide written informed consent

结局指标

主要结局

Evaluate the feasibility of PET/CT imaging with 68Ga-MY6349 for the non-invasive assessment of Trop2 expression in various cancer types.

时间窗: 1 week

Tumor Trop2 expression analysis in a fresh biopsy sample will be correlated to 68Ga-MY6349 tumor uptake, evaluated by measuring standardized uptake value (SUV) on the 68Ga-MY6349 PET/CT.

次要结局

  • Description of 68Ga-MY6349 uptake by measuring standardized uptake value (SUV) in various types of tumors(1 week)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验